Stocks › CAMP
Camp4 Therapeutics Corp
CAMP·Nasdaq·
United States·USD
United States·USD$3.96
-0.05 (-1.25%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
CAMP
Camp4 Therapeutics Corp · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CAMPS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CAMP by members of U.S. Congress · 2 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 James B. RenacciHouse · R · OH |
CAMPCamp4 Therapeutics Corp · Stock |
Sale $15,001 - $50,000 |
Oct 20, 2015 | Oct 2, 2015 | Filing ↗ |
| James B. RenacciHouse · R · OH |
CAMPCamp4 Therapeutics Corp · Stock |
Purchase $15,001 - $50,000 |
Feb 10, 2015 | Jan 28, 2015 | Filing ↗ |
Whale Activity
Position changes in CAMP reported for 2026-06-30 by 7 tracked institutional filers
- Increased1
- New1
- Held0
- Decreased3
- Closed1
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 1.6M | $7.2M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | $6.7M | decreased |
| Stonepine Capital Management, LLC | 1.4M | $6.1M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 220.7K | $965K | new |
| TWO SIGMA INVESTMENTS, LP | 104.6K | $457K | decreased |
| MILLENNIUM MANAGEMENT LLC | 43.9K | $192K | decreased |
| Point72 Asset Management | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CAMP insiders, by quarter · Form 4
Recent Insider Transactions
994 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Gold KellyChief Financial Officer | Purchase | +10.0K | $3.96 | $40K | Aug 31, 2026 | Form 4 ↗ |
| Schwab Andrew J.Director · Director | Sale | −400.0K | $4.04 | $1.6M | Aug 27, 2026 | Form 4 ↗ |
| Schwab Andrew J.Director · Director | Sale | −10 | $4.50 | $45 | Aug 24, 2026 | Form 4 ↗ |
| Schwab Andrew J.Director · Director | Sale | −32.0K | $4.50 | $144K | Aug 21, 2026 | Form 4 ↗ |
| Schwab Andrew J.Director · Director | Sale | −114.7K | $4.54 | $521K | Aug 20, 2026 | Form 4 ↗ |
| Schwab Andrew J.Director · Director | Sale | −45.1K | $4.76 | $215K | Aug 19, 2026 | Form 4 ↗ |
| Tardiff DanielChief Scientific Officer | Sale | −1,738 | $4.76 | $8K | Aug 19, 2026 | Form 4 ↗ |
| Young Richard ADirector · Director | Purchase | +16.4K | n/c | — | Aug 3, 2026 | Form 4 ↗ |
| Maricich YuriChief Medical Officer | Purchase | +6,551 | n/c | — | Aug 3, 2026 | Form 4 ↗ |
| Gold KellyChief Financial Officer | Purchase | +6,551 | n/c | — | Aug 3, 2026 | Form 4 ↗ |
| Mandel-Brehm JoshChief Executive Officer · Director | Purchase | +6,551 | n/c | — | Aug 3, 2026 | Form 4 ↗ |
| Schwab Andrew J.Director · 10% owner | Grant / award | +2.9M | $1.53 | $4.5M | Sep 11, 2025 | Form 4 ↗ |
| 5AM Ventures VII, L.P.10% owner | Purchase | +2.9M | $1.53 | $4.5M | Sep 11, 2025 | Form 4 ↗ |
| Gold KellyChief Financial Officer | Purchase | +6,060 | $1.65 | $10K | Sep 11, 2025 | Form 4 ↗ |
| Mandel-Brehm JoshChief Executive Officer · Director | Purchase | +6,060 | $1.65 | $10K | Sep 11, 2025 | Form 4 ↗ |
| Maricich YuriChief Medical Officer | Purchase | +6,060 | $1.65 | $10K | Sep 11, 2025 | Form 4 ↗ |
| Young Richard ADirector | Purchase | +15.2K | $1.65 | $25K | Sep 11, 2025 | Form 4 ↗ |
| Polaris Management Co. VII, L.L.C.10% owner | Purchase | +85.5K | $1.53 | $131K | Sep 11, 2025 | Form 4 ↗ |
| Polaris Management Co. VII, L.L.C.10% owner | Purchase | +1.2M | $1.53 | $1.9M | Sep 11, 2025 | Form 4 ↗ |
| Nashat AmirDirector · 10% owner | Purchase | +85.5K | $1.53 | $131K | Sep 11, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CAMP · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Select Biotechnology Portfolio Fidelity Select Portfolios | 1.3M | $5.8M | 0.11% | May 31, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.1M | $5.0M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 453.0K | $2.0M | 0.00% | Jun 30, 2026 |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 400.1K | $1.8M | 0.00% | May 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 357.2K | $1.6M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 341.8K | $1.2M | 0.00% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF iShares Trust | 267.7K | $1.2M | 0.01% | Jun 30, 2026 |
| Victory Science & Technology Fund Victory Portfolios III | 226.6K | $782K | 0.05% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 165.1K | $725K | 0.00% | May 31, 2026 |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 109.5K | $481K | 0.00% | May 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list CAMP's shares (CUSIP 13463J101), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Kush ParmarSCHEDULE 13D/A · activist (13D) · 6.4M shares9.9%
Aug 31, 2026 · ↗ - Andrew J. SchwabSCHEDULE 13D/A · activist (13D) · 6.4M shares9.9%
Aug 31, 2026 · ↗ - 5AM Opportunities II (GP), LLCSCHEDULE 13D/A · activist (13D) · 302.8K shares0.5%
Aug 31, 2026 · ↗ - 5AM Opportunities II, L.P.SCHEDULE 13D/A · activist (13D) · 302.8K shares0.5%
Aug 31, 2026 · ↗ - 5AM Partners VII, LLCSCHEDULE 13D/A · activist (13D) · 4.0M shares6.3%
Aug 31, 2026 · ↗ - 5AM Ventures VII, L.P.SCHEDULE 13D/A · activist (13D) · 4.0M shares6.3%
Aug 31, 2026 · ↗ - 5AM Partners VI, LLCSCHEDULE 13D/A · activist (13D) · 2.0M shares3.2%
Aug 31, 2026 · ↗ - 5AM Ventures VI, L.P.SCHEDULE 13D/A · activist (13D) · 2.0M shares3.2%
Aug 31, 2026 · ↗ - Amy SchulmanSCHEDULE 13D/A · activist (13D) · 909.1K shares1.4%
Aug 19, 2026 · ↗ - Brian CheeSCHEDULE 13D/A · activist (13D) · 909.1K shares1.4%
Aug 19, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Camp4 Therapeutics Corp as client
No lobbying filings found naming Camp4 Therapeutics Corp as the client.
Government Contracts
Federal awards to Camp4 Therapeutics Corp · USAspending
No federal contract awards found for Camp4 Therapeutics Corp.
U.S. Patents
Recent USPTO applications naming Camp4 Therapeutics Corp
No USPTO patent applications found for Camp4 Therapeutics Corp.
Annual Financials
From CAMP's 10-K filings · XBRL
No annual XBRL figures on record for CAMP. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in CAMP's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsSep 28, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 13, 2026
EDGAR ↗ - 8-K · Items 1.01, 3.02, 7.01, 9.01Material agreement · Unregistered sale of equity · Reg FD disclosureAug 4, 2026
EDGAR ↗ - 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsJul 27, 2026
EDGAR ↗ - 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJun 12, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureMay 14, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
EDGAR ↗
About Camp4 Therapeutics Corp
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersWATERTOWN, MA
IncorporatedDE
SEC CIK0001736730 ↗